home news forum careers events suppliers solutions markets expos directories catalogs resources advertise contacts
 
News Page

The news
and
beyond the news
Index of news sources
All Africa Asia/Pacific Europe Latin America Middle East North America
  Topics
  Species
Archives
News archive 1997-2008
 

Novozymes - Interim report for the first half of 2015


Denmark
August 6, 2015

  • Full-year profit outlook maintained
  • Sales growth expectations revised
Sales in the first half of 2015 grew by 5% organically and by 15% in DKK compared with 1H 2014. EBIT grew by 12%, and the EBIT margin was 27.2%. Adjusting for the one-time impact from The BioAg Alliance in Q1 2014, EBIT grew by ~20%, and the EBIT margin expanded by ~1 percentage point compared with 1H 2014. The EBIT margin improvement was mainly due to currencies and operational efficiencies. Net profit grew by 8%, and free cash flow before acquisitions came in at DKK 1,616 million.

The 2015 outlook for organic sales growth is revised to 4-7% (7-9% at previous guidance). Sales in DKK are now expected to increase by 13-16% (16-18% at previous guidance). The expectation for EBIT margin is increased to 27-28% (~27% at previous guidance). The expectations for EBIT growth, net profit growth, cash flow and ROIC are unchanged.

2015_37_Q22015_CompanyAnnouncement_EN_FINAL.pdfPlease read the full announcement in PDF format



More news from: Novonesis


Website: https://www.novonesis.com/en

Published: August 6, 2015

The news item on this page is copyright by the organization where it originated
Fair use notice


Copyright @ 1992-2024 SeedQuest - All rights reserved